32 results on '"Shaw, Bronwen"'
Search Results
2. Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia
3. Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102
4. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
5. International Blood and Marrow Registries: trends on long‐term data collection
6. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
7. Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patients
8. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes
9. Long-Term Outcomes Among 2-Year Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Diffuse Large B-Cell Lymphoma
10. Post‐transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)
11. Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma
12. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors
13. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful
14. Alpha‐1‐antitrypsin for the treatment of steroid‐refractory acute gastrointestinal graft‐versus‐host disease
15. Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield
16. Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord
17. Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols
18. Sexual health in hematopoietic stem cell transplant recipients
19. Transplant‐acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies
20. Female donors and donors who are lighter than their recipient are less likely to meet the CD34+ cell dose requested for peripheral blood stem cell transplantation
21. High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD
22. Unrelated donor peripheral blood stem cell transplants incorporating pre‐transplant in‐vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft‐versus‐host disease
23. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation
24. Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE
25. Outcomes following 50mgversus100mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia
26. Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma
27. Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease
28. The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma
29. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
30. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR).
31. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
32. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.